asthme et grossesse

Jean Francois KULIK kulik at univ-lille2.fr
Tue Jun 16 11:58:09 EST 1998


--------------31F979EF2BD8C1833C666C66
Content-Type: text/plain; charset=iso-8859-1
Content-Transfer-Encoding: quoted-printable

Salutations,
j'ai lu votre message dans le groupe de news de bionet.women-in-bio :
j'ai fait une recherche dans medscape pour vous
(http://www.medscape.com)
sur une interrogation : asthma in pregnancy.
Quelques-unes  des r=E9f=E9rences retrouv=E9es : (j'en ai s=E9lectionn=E9=

quelques-unes mais je pense que vous pouvez recommencez la manip pour
avoir une information plus exhaustive)
En esp=E8rant que =E7a vous aidera.
Dr Jean-Fran=E7ois Kulik-Universit=E9 de Lille II

 Search for "(asthma in pregnancy)" in Medscape's free Full-Text
Articles or the Medscape Bookstore
Database: med93-94 -- Record 1 of 7 selected.

Title
     Asthma in pregnancy. National Asthma Education Program Working
Group on Asthma and Pregnancy. National Institutes of Health, National
Heart,
     Lung and Blood Institute [see comments]
Author
     Clark SL
Address
     National Institutes of Health, Bethesda, Maryland.
Source
     Obstet Gynecol, 82(6):1036-40 1993 Dec
Abstract
     This manuscript is a summary of a comprehensive report dealing with
asthma and pregnancy issued by the working group on Asthma and
Pregnancy,
     National Institutes of Health (NIH), National Heart, Lung, and
Blood Institute. The report was developed by a panel of obstetricians,
pharmacologists,
     internists, allergists, and pulmonologists, who met over an
18-month period under the auspices of the NIH. Undertreatment of
pregnant asthmatics, partially
     because of unfounded fears of adverse pharmacologic effects on the
developing fetus, remains the major problem in the management of asthma
during
     pregnancy in the United States. The four key components of asthma
management during pregnancy are: 1) objective assessment of maternal
lung function
     and fetal well-being, 2) avoidance or control of environmental
precipitating factors, 3) pharmacologic therapy, and 4) patient
education.
Language
     Eng
Unique Identifier
     94050974



MESH Headings
     Asthma ET/PP/*TH ; Female ; Human ; Pregnancy ; Pregnancy
Complications ET/PP/*TH



Publication Type
     JOURNAL ARTICLE
ISSN
     0029-7844
Country of Publication
     UNITED STATES


Database: med93-94 -- Record 2 of 7 selected.

Title
     [Asthma in pregnancy. Physiopathological, clinical, and therapeutic
aspects]
Author
     Liccardi G; Romis L; Scalera S; Di Gennaro S; Maddaloni G
Address
     Dipartimento di Malattie Respiratorie, Ospedale A. Cardarelli,
Napoli.
Source
     Minerva Med, 84(12):663-70 1993 Dec
Abstract
     The constantly increasing frequency of asthmatic pathologies in the
general population has consequently led to a greater number of cases of
bronchial asthma
     in pregnant women. In normal conditions the respiratory function
undergoes numerous modifications in pregnancy, above all increased
ventilation/minute and
     oxygen consumption. Likewise, asthma has a number of obviously
negative effects both on the pregnant woman and the developing foetus.
The clinical course
     of asthma may also be influenced by the start of pregnancy in
various unforeseeable ways. All these aspects highlight the considerable
difficulties of treating
     bronchial asthma during pregnancy, not to mention the medicolegal
responsibility which the obstetrician and doctor must assume. In this
respect it is vitally
     important to emphasize that pregnant women suffering from asthma
must be treated in the same way as those who are not pregnant, and both
prophylactic and
     anti-dysreactive pharmacological treatment must be administered at
an early stage right up until the time of birth. Since these drugs are
above all of the aerosol
     type, their potential secondary and/or teratogenic effects is
considered extremely low and to all extents absolutely favourable in
relation to the cost/benefit ratio.
     In fact, it is certainly less damaging for the pregnant woman to
take these drugs, even in the first trimester of pregnancy, rather than
run the risk of an attack of
     asthma with unforeseeable results. It is therefore enormously
important to ensure that both the doctor and pregnant woman are
adequately informed regarding
     preventive and pharmacological strategies for bronchial asthma.
Language
     Ita
Unique Identifier
     94173442



MESH Headings
     Asthma */PP/TH ; English Abstract ; Female ; Human ; Labor ;
Pregnancy ; Pregnancy Complications */PP/TH ; Respiration



Publication Type
     JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
     0026-4806
Country of Publication
     ITALY


Database: med95-97 -- Record 3 of 7 selected.

Title
     [Asthma and pregnancy]
Author
     Gazca Aguilar A; del R=B4io Navarro B; Sienra Monge JJ; Linares
Zapien FJ
Address
     Adscrito al servicio de alergia e inmunolog=B4ia cl=B4inica, Hospita=
l
Infantil de M=B4exico Federico G=B4omez M=B4exico, D.F.
Source
     Ginecol Obstet Mex, 63():460-6 1995 Nov
Abstract
     Asthma is among the diseases that may complicate pregnancy. Asthma
affects up to 4% of the pregnant women. Uncontrolled asthma may impair
the
     proper oxygenation of both mother and child. According to asthma
severity clinical manifestations may be unapparent or apparent requiring
hospital treatment.
     It is necessary that pregnant asthmatic woman check daily the
peak-flow by portable peak-flow meters. The asthma pharmacological
treatment should
     consider the changes in the physiology of the pregnancy, such as
low albumin and carrier proteins for the drugs inducing high levels of
free active drugs. This
     point is important for theophylline, besides the low drug
clearance. Bronchodilator should be used as they are required, using the
inhaled forms, as well as short
     term corticoid courses. The goal of the treatment is to control the
symptoms, avoid relapse and keep the ventilatory function close to the
normal, in order to
     achieve a satisfactory state of the mother and the children.
Language
     Spa
Unique Identifier
     96123016



MESH Headings
     Adrenal Cortex Hormones TU ; Asthma */DI/DT ; Bronchodilator Agents
TU ; Comparative Study ; English Abstract ; Female ; Human ; Peak
Expiratory
     Flow Rate ; Pregnancy ; Pregnancy Complications */DI/DT ; Prognosis
; Respiratory Function Tests ; Theophylline TU



Publication Type
     JOURNAL ARTICLE
ISSN
     0300-9041
Country of Publication
     MEXICO


Database: med93-94 -- Record 4 of 7 selected.

Title
     Management of asthma in pregnancy.
Author
     Black PA
Source
     Prof Nurse, 9(1):42-4 1993 Oct
Abstract
     1. Approximately a third of mothers find their asthma improves
during pregnancy, while one third stay the same and the remainder's
asthma worsens. 2.
     Asthma needs to be controlled; if it is not, the fetus may receive
insufficient oxygen. 3. The two main types of asthma arise from
different causes and have
     different patterns of inheritance, although in many cases the
originating stimulus is the same. 4. A polluted environment contributes
to the production of allergens
     and irritants which trigger asthma in susceptible people.
Language
     Eng
Unique Identifier
     94022473



MESH Headings
     Air Pollution PC ; Asthma *CO/NU ; Female ; Human ; Pregnancy ;
Pregnancy Complications */NU ; Relaxation Techniques



Publication Type
     JOURNAL ARTICLE
ISSN
     0266-8130
Country of Publication
     ENGLAND


Database: med95-97 -- Record 5 of 7 selected.

Title
     Asthma in pregnancy.
Author
     Witlin AG
Address
     Department of Obstetrics and Gynecology, The University of Texas
Medical Branch at Galveston, 77555-0587, USA.
Source
     Semin Perinatol, 21(4):284-97 1997 Aug
Abstract
     Asthma is the most common respiratory crisis complicating
pregnancy. Asthma is a heterogeneous lung disease characterized by
reversible airway
     obstruction, airway inflammation, and airway hyperresponsiveness.
The cornerstone of management involves the use of inhaled beta2-receptor
agonists and
     inhaled corticosteroids. Poor control and exacerbations of asthma
during pregnancy may result in maternal hypoxia with resultant decreases
in fetal oxygen
     saturation and fetal hypoxia, which has been associated with an
increased incidence of low birth weight, intrauterine growth
restriction, and cesarean delivery.
     Therefore, the goals of therapy are to maintain normal pulmonary
function, control symptoms, prevent exacerbations, avoid adverse effects
of medication, and
     deliver a healthy baby.
Language
     Eng
Unique Identifier
     97442168



MESH Headings
     Asthma */DI/DT/ET/MO/PP ; Female ; Human ; Labor Complications ;
Pregnancy ; Pregnancy Complications *



Publication Type
     JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
     0146-0005
Country of Publication
     UNITED STATES


Database: med93-94 -- Record 6 of 7 selected.

Title
     [Asthma and pregnancy: some immunologic aspects]
Author
     Alfonso Fern=B4andez LA; M=B4arquez Chac=B4on A; Estruch Fajardo I;
G=B4omez Echevarr=B4ia AH; Lastra Alfonso G
Address
     Facultad n=B4umero uno, Ciudad de La Habana, Cuba.
Source
     Rev Alerg Mex, 41(1):4-8 1994 Jan-Feb
Abstract
     We studied two groups of pregnant women: 30 asthmatic and 20 non-
asthmatic ones (as control), within a eleven-month period. We filled
clinical data with
     inclusion and exclusion criteria for our investigation. We
performed tests for determination of E, G, A and M immunoglobulins; and
spontaneous rosettes tests
     and lymphocytic CD4+ and CD8+ subpopulations, as well. We found
high IgE levels in the asthmatic pregnant women, in each pregnancy
quarter. In relation
     to IgG and IgA we found a diminishing tendency from the beginning
to the end of pregnancy, with statistical meaning, in beth groups of
women. We didn't get
     significant variations for IgM, spontaneous rosettes and
lymphocytic CD4+ and CD8+ subpopulations levels, in any of the two
pregnant groups, in any of three
     pregnancy quarters, in our investigation.
Language
     Spa
Unique Identifier
     94373116



MESH Headings


--------------31F979EF2BD8C1833C666C66
Content-Type: text/html; charset=us-ascii
Content-Transfer-Encoding: 7bit

<HTML>
Salutations,
<BR>j'ai lu votre message dans le groupe de news de bionet.women-in-bio
:
<BR>j'ai fait une recherche dans medscape pour vous (<A HREF="http://www.medscape.com">http://www.medscape.com</A>)
<BR>sur une interrogation : asthma in pregnancy.
<BR>Quelques-unes&nbsp; des r&eacute;f&eacute;rences retrouv&eacute;es
: (j'en ai s&eacute;lectionn&eacute; quelques-unes mais je pense que vous
pouvez recommencez la manip pour avoir une information plus exhaustive)
<BR><B>En esp&egrave;rant que &ccedil;a vous aidera.</B>
<BR><B>Dr Jean-Fran&ccedil;ois Kulik-Universit&eacute; de Lille II</B>

<P>&nbsp;Search for "(asthma in pregnancy)" in Medscape's free Full-Text
Articles or the Medscape Bookstore
<BR>Database: med93-94 -- Record 1 of 7 selected.

<P>Title
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Asthma in pregnancy. National Asthma Education
Program Working Group on Asthma and Pregnancy. National Institutes of Health,
National Heart,
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Lung and Blood Institute [see comments]
<BR>Author
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Clark SL
<BR>Address
<BR>&nbsp;&nbsp;&nbsp;&nbsp; National Institutes of Health, Bethesda, Maryland.
<BR>Source
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Obstet Gynecol, 82(6):1036-40 1993 Dec
<BR>Abstract
<BR>&nbsp;&nbsp;&nbsp;&nbsp; This manuscript is a summary of a comprehensive
report dealing with asthma and pregnancy issued by the working group on
Asthma and Pregnancy,
<BR>&nbsp;&nbsp;&nbsp;&nbsp; National Institutes of Health (NIH), National
Heart, Lung, and Blood Institute. The report was developed by a panel of
obstetricians, pharmacologists,
<BR>&nbsp;&nbsp;&nbsp;&nbsp; internists, allergists, and pulmonologists,
who met over an 18-month period under the auspices of the NIH. Undertreatment
of pregnant asthmatics, partially
<BR>&nbsp;&nbsp;&nbsp;&nbsp; because of unfounded fears of adverse pharmacologic
effects on the developing fetus, remains the major problem in the management
of asthma during
<BR>&nbsp;&nbsp;&nbsp;&nbsp; pregnancy in the United States. The four key
components of asthma management during pregnancy are: 1) objective assessment
of maternal lung function
<BR>&nbsp;&nbsp;&nbsp;&nbsp; and fetal well-being, 2) avoidance or control
of environmental precipitating factors, 3) pharmacologic therapy, and 4)
patient education.
<BR>Language
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Eng
<BR>Unique Identifier
<BR>&nbsp;&nbsp;&nbsp;&nbsp; 94050974
<BR>&nbsp;
<BR>&nbsp;

<P>MESH Headings
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Asthma ET/PP/*TH ; Female ; Human ; Pregnancy
; Pregnancy Complications ET/PP/*TH
<BR>&nbsp;
<BR>&nbsp;

<P>Publication Type
<BR>&nbsp;&nbsp;&nbsp;&nbsp; JOURNAL ARTICLE
<BR>ISSN
<BR>&nbsp;&nbsp;&nbsp;&nbsp; 0029-7844
<BR>Country of Publication
<BR>&nbsp;&nbsp;&nbsp;&nbsp; UNITED STATES
<BR>&nbsp;

<P>Database: med93-94 -- Record 2 of 7 selected.

<P>Title
<BR>&nbsp;&nbsp;&nbsp;&nbsp; [Asthma in pregnancy. Physiopathological,
clinical, and therapeutic aspects]
<BR>Author
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Liccardi G; Romis L; Scalera S; Di Gennaro
S; Maddaloni G
<BR>Address
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Dipartimento di Malattie Respiratorie, Ospedale
A. Cardarelli, Napoli.
<BR>Source
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Minerva Med, 84(12):663-70 1993 Dec
<BR>Abstract
<BR>&nbsp;&nbsp;&nbsp;&nbsp; The constantly increasing frequency of asthmatic
pathologies in the general population has consequently led to a greater
number of cases of bronchial asthma
<BR>&nbsp;&nbsp;&nbsp;&nbsp; in pregnant women. In normal conditions the
respiratory function undergoes numerous modifications in pregnancy, above
all increased ventilation/minute and
<BR>&nbsp;&nbsp;&nbsp;&nbsp; oxygen consumption. Likewise, asthma has a
number of obviously negative effects both on the pregnant woman and the
developing foetus. The clinical course
<BR>&nbsp;&nbsp;&nbsp;&nbsp; of asthma may also be influenced by the start
of pregnancy in various unforeseeable ways. All these aspects highlight
the considerable difficulties of treating
<BR>&nbsp;&nbsp;&nbsp;&nbsp; bronchial asthma during pregnancy, not to
mention the medicolegal responsibility which the obstetrician and doctor
must assume. In this respect it is vitally
<BR>&nbsp;&nbsp;&nbsp;&nbsp; important to emphasize that pregnant women
suffering from asthma must be treated in the same way as those who are
not pregnant, and both prophylactic and
<BR>&nbsp;&nbsp;&nbsp;&nbsp; anti-dysreactive pharmacological treatment
must be administered at an early stage right up until the time of birth.
Since these drugs are above all of the aerosol
<BR>&nbsp;&nbsp;&nbsp;&nbsp; type, their potential secondary and/or teratogenic
effects is considered extremely low and to all extents absolutely favourable
in relation to the cost/benefit ratio.
<BR>&nbsp;&nbsp;&nbsp;&nbsp; In fact, it is certainly less damaging for
the pregnant woman to take these drugs, even in the first trimester of
pregnancy, rather than run the risk of an attack of
<BR>&nbsp;&nbsp;&nbsp;&nbsp; asthma with unforeseeable results. It is therefore
enormously important to ensure that both the doctor and pregnant woman
are adequately informed regarding
<BR>&nbsp;&nbsp;&nbsp;&nbsp; preventive and pharmacological strategies
for bronchial asthma.
<BR>Language
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Ita
<BR>Unique Identifier
<BR>&nbsp;&nbsp;&nbsp;&nbsp; 94173442
<BR>&nbsp;
<BR>&nbsp;

<P>MESH Headings
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Asthma */PP/TH ; English Abstract ; Female
; Human ; Labor ; Pregnancy ; Pregnancy Complications */PP/TH ; Respiration
<BR>&nbsp;
<BR>&nbsp;

<P>Publication Type
<BR>&nbsp;&nbsp;&nbsp;&nbsp; JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
<BR>ISSN
<BR>&nbsp;&nbsp;&nbsp;&nbsp; 0026-4806
<BR>Country of Publication
<BR>&nbsp;&nbsp;&nbsp;&nbsp; ITALY
<BR>&nbsp;

<P>Database: med95-97 -- Record 3 of 7 selected.

<P>Title
<BR>&nbsp;&nbsp;&nbsp;&nbsp; [Asthma and pregnancy]
<BR>Author
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Gazca Aguilar A; del R&acute;io Navarro B;
Sienra Monge JJ; Linares Zapien FJ
<BR>Address
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Adscrito al servicio de alergia e inmunolog&acute;ia
cl&acute;inica, Hospital Infantil de M&acute;exico Federico G&acute;omez
M&acute;exico, D.F.
<BR>Source
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Ginecol Obstet Mex, 63():460-6 1995 Nov
<BR>Abstract
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Asthma is among the diseases that may complicate
pregnancy. Asthma affects up to 4% of the pregnant women. Uncontrolled
asthma may impair the
<BR>&nbsp;&nbsp;&nbsp;&nbsp; proper oxygenation of both mother and child.
According to asthma severity clinical manifestations may be unapparent
or apparent requiring hospital treatment.
<BR>&nbsp;&nbsp;&nbsp;&nbsp; It is necessary that pregnant asthmatic woman
check daily the peak-flow by portable peak-flow meters. The asthma pharmacological
treatment should
<BR>&nbsp;&nbsp;&nbsp;&nbsp; consider the changes in the physiology of
the pregnancy, such as low albumin and carrier proteins for the drugs inducing
high levels of free active drugs. This
<BR>&nbsp;&nbsp;&nbsp;&nbsp; point is important for theophylline, besides
the low drug clearance. Bronchodilator should be used as they are required,
using the inhaled forms, as well as short
<BR>&nbsp;&nbsp;&nbsp;&nbsp; term corticoid courses. The goal of the treatment
is to control the symptoms, avoid relapse and keep the ventilatory function
close to the normal, in order to
<BR>&nbsp;&nbsp;&nbsp;&nbsp; achieve a satisfactory state of the mother
and the children.
<BR>Language
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Spa
<BR>Unique Identifier
<BR>&nbsp;&nbsp;&nbsp;&nbsp; 96123016
<BR>&nbsp;
<BR>&nbsp;

<P>MESH Headings
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Adrenal Cortex Hormones TU ; Asthma */DI/DT
; Bronchodilator Agents TU ; Comparative Study ; English Abstract ; Female
; Human ; Peak Expiratory
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Flow Rate ; Pregnancy ; Pregnancy Complications
*/DI/DT ; Prognosis ; Respiratory Function Tests ; Theophylline TU
<BR>&nbsp;
<BR>&nbsp;

<P>Publication Type
<BR>&nbsp;&nbsp;&nbsp;&nbsp; JOURNAL ARTICLE
<BR>ISSN
<BR>&nbsp;&nbsp;&nbsp;&nbsp; 0300-9041
<BR>Country of Publication
<BR>&nbsp;&nbsp;&nbsp;&nbsp; MEXICO
<BR>&nbsp;

<P>Database: med93-94 -- Record 4 of 7 selected.

<P>Title
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Management of asthma in pregnancy.
<BR>Author
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Black PA
<BR>Source
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Prof Nurse, 9(1):42-4 1993 Oct
<BR>Abstract
<BR>&nbsp;&nbsp;&nbsp;&nbsp; 1. Approximately a third of mothers find their
asthma improves during pregnancy, while one third stay the same and the
remainder's asthma worsens. 2.
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Asthma needs to be controlled; if it is not,
the fetus may receive insufficient oxygen. 3. The two main types of asthma
arise from different causes and have
<BR>&nbsp;&nbsp;&nbsp;&nbsp; different patterns of inheritance, although
in many cases the originating stimulus is the same. 4. A polluted environment
contributes to the production of allergens
<BR>&nbsp;&nbsp;&nbsp;&nbsp; and irritants which trigger asthma in susceptible
people.
<BR>Language
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Eng
<BR>Unique Identifier
<BR>&nbsp;&nbsp;&nbsp;&nbsp; 94022473
<BR>&nbsp;
<BR>&nbsp;

<P>MESH Headings
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Air Pollution PC ; Asthma *CO/NU ; Female
; Human ; Pregnancy ; Pregnancy Complications */NU ; Relaxation Techniques
<BR>&nbsp;
<BR>&nbsp;

<P>Publication Type
<BR>&nbsp;&nbsp;&nbsp;&nbsp; JOURNAL ARTICLE
<BR>ISSN
<BR>&nbsp;&nbsp;&nbsp;&nbsp; 0266-8130
<BR>Country of Publication
<BR>&nbsp;&nbsp;&nbsp;&nbsp; ENGLAND
<BR>&nbsp;

<P>Database: med95-97 -- Record 5 of 7 selected.

<P>Title
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Asthma in pregnancy.
<BR>Author
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Witlin AG
<BR>Address
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Department of Obstetrics and Gynecology, The
University of Texas Medical Branch at Galveston, 77555-0587, USA.
<BR>Source
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Semin Perinatol, 21(4):284-97 1997 Aug
<BR>Abstract
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Asthma is the most common respiratory crisis
complicating pregnancy. Asthma is a heterogeneous lung disease characterized
by reversible airway
<BR>&nbsp;&nbsp;&nbsp;&nbsp; obstruction, airway inflammation, and airway
hyperresponsiveness. The cornerstone of management involves the use of
inhaled beta2-receptor agonists and
<BR>&nbsp;&nbsp;&nbsp;&nbsp; inhaled corticosteroids. Poor control and
exacerbations of asthma during pregnancy may result in maternal hypoxia
with resultant decreases in fetal oxygen
<BR>&nbsp;&nbsp;&nbsp;&nbsp; saturation and fetal hypoxia, which has been
associated with an increased incidence of low birth weight, intrauterine
growth restriction, and cesarean delivery.
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Therefore, the goals of therapy are to maintain
normal pulmonary function, control symptoms, prevent exacerbations, avoid
adverse effects of medication, and
<BR>&nbsp;&nbsp;&nbsp;&nbsp; deliver a healthy baby.
<BR>Language
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Eng
<BR>Unique Identifier
<BR>&nbsp;&nbsp;&nbsp;&nbsp; 97442168
<BR>&nbsp;
<BR>&nbsp;

<P>MESH Headings
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Asthma */DI/DT/ET/MO/PP ; Female ; Human ;
Labor Complications ; Pregnancy ; Pregnancy Complications *
<BR>&nbsp;
<BR>&nbsp;

<P>Publication Type
<BR>&nbsp;&nbsp;&nbsp;&nbsp; JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
<BR>ISSN
<BR>&nbsp;&nbsp;&nbsp;&nbsp; 0146-0005
<BR>Country of Publication
<BR>&nbsp;&nbsp;&nbsp;&nbsp; UNITED STATES
<BR>&nbsp;

<P>Database: med93-94 -- Record 6 of 7 selected.

<P>Title
<BR>&nbsp;&nbsp;&nbsp;&nbsp; [Asthma and pregnancy: some immunologic aspects]
<BR>Author
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Alfonso Fern&acute;andez LA; M&acute;arquez
Chac&acute;on A; Estruch Fajardo I; G&acute;omez Echevarr&acute;ia AH;
Lastra Alfonso G
<BR>Address
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Facultad n&acute;umero uno, Ciudad de La Habana,
Cuba.
<BR>Source
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Rev Alerg Mex, 41(1):4-8 1994 Jan-Feb
<BR>Abstract
<BR>&nbsp;&nbsp;&nbsp;&nbsp; We studied two groups of pregnant women: 30
asthmatic and 20 non- asthmatic ones (as control), within a eleven-month
period. We filled clinical data with
<BR>&nbsp;&nbsp;&nbsp;&nbsp; inclusion and exclusion criteria for our investigation.
We performed tests for determination of E, G, A and M immunoglobulins;
and spontaneous rosettes tests
<BR>&nbsp;&nbsp;&nbsp;&nbsp; and lymphocytic CD4+ and CD8+ subpopulations,
as well. We found high IgE levels in the asthmatic pregnant women, in each
pregnancy quarter. In relation
<BR>&nbsp;&nbsp;&nbsp;&nbsp; to IgG and IgA we found a diminishing tendency
>From the beginning to the end of pregnancy, with statistical meaning, in
beth groups of women. We didn't get
<BR>&nbsp;&nbsp;&nbsp;&nbsp; significant variations for IgM, spontaneous
rosettes and lymphocytic CD4+ and CD8+ subpopulations levels, in any of
the two pregnant groups, in any of three
<BR>&nbsp;&nbsp;&nbsp;&nbsp; pregnancy quarters, in our investigation.
<BR>Language
<BR>&nbsp;&nbsp;&nbsp;&nbsp; Spa
<BR>Unique Identifier
<BR>&nbsp;&nbsp;&nbsp;&nbsp; 94373116
<BR>&nbsp;
<BR>&nbsp;

<P>MESH Headings
<BR>&nbsp;</HTML>

--------------31F979EF2BD8C1833C666C66--





More information about the Womenbio mailing list